301263.SZ
泰恩康
SZSE · F 批发零售 · CN
CNY 18.35
−3.57%Aug 20, 2026, 10:51 UTC
Taienkang's wholly-owned subsidiary Shandong Huabo Kaisheng Biotechnology Co., Ltd. received the Drug Clinical Trial Approval Notice issued by the National Medical Products Administration for cisplatin polymer micelles for injection.
Source:Aug 7, 2026, 09:38 UTC
Tai Enkang's wholly-owned subsidiary Huabo Kaisheng won the bid for baricitinib tablets (2mg*28 tablets/box) in the 12th national centralized drug procurement.
Source: